Pipeline™ Vantage Embolization Device With Shield Technology™ for Wide-Necked Intracranial Aneurysms (ADVANCE)
Stopped early · Not applicable
Conditions studied: Intracranial Aneurysm
In brief
The purpose of this study is to assess the safety and effectiveness of the Pipeline™ Vantage Embolization Device with Shield Technology™ in the treatment of intracranial aneurysms within the intended indication for use.
Key facts
- Study ID
- NCT03873714
- Run by
- Medtronic Neurovascular Clinical Affairs
- People needed
- 14
- Starts
- 2020-04-02
- Expected to finish
- 2023-09-18
- Last updated by the study team
- 2025-06-19
Who can join
Age: 22 and older, up to 80. Sex: any. Healthy volunteers: not accepted.
Where it is running
- Baptist Medical Center Jacksonville — Jacksonville, Florida, United States
- Jackson Memorial Hospital — Miami, Florida, United States
- Stony Brook University Hospital — Stony Brook, New York, United States
Full record on ClinicalTrials.gov
Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.